| Literature DB >> 23527858 |
Sereyvath Yoeun1, Randeep Rakwal, Oksoo Han.
Abstract
Phylogenetic and amino acid sequence analysis indicated that rice allene oxide synthase-1 (OsAOS1) is CYP74, and is clearly distinct from CYP74B, C and D subfamilies. Regio- and stereo-chemical analysis revealed the dual substrate specificity of OsAOS1 for (cis,trans)-configurational isomers of 13(S)- and 9(S)-hydroperoxyoctadecadienoic acid. GC-MS analysis showed that OsAOS1 converts 13(S)- and 9(S)-hydroperoxyoctadecadi(tri)enoic acid into their corresponding allene oxide. UV-Visible spectral analysis of native OsAOS1 revealed a Soret maximum at 393 nm, which shifted to 424 nm with several clean isobestic points upon binding of OsAOS1 to imidazole. The spectral shift induced by imidazole correlated with inhibition of OsAOS1 activity, implying that imidazole may coordinate to ferric heme iron, triggering a heme-iron transition from high spin state to low spin state. The implications and significance of a putative type II ligand-induced spin state transition in OsAOS1 are discussed.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23527858 PMCID: PMC4133873 DOI: 10.5483/bmbrep.2013.46.3.117
Source DB: PubMed Journal: BMB Rep ISSN: 1976-6696 Impact factor: 4.778
Kinetic parameters and comparison of AOSa and HPL activity of OsAOS1
| Substrate | Relative specific activities (%) | ||||
|---|---|---|---|---|---|
|
| |||||
| AOS activity | HPL activity | ||||
|
| |||||
| 13(S)-HPODE | 12.5 (15.0 ± 7.2b) | 494.5 (108 ± 21b) | 39.6 × 106 | 91.4 (80c) | 8.6 (15c) |
| 13(S)-HPODE | 12.3 | 537.8 | 43.7 × 106 | 98.2 (81c) | 1.8 (12c) |
| 9(S)-HPODE | 6.9 | 44.9 | 6.5 × 106 | 90.3 | 9.7 |
| 9(S)-HPODE | 8.6 | 17.5 | 2.0 × 106 | 98.4 | 1.6 |
aAOS activity was estimated by subtraction of the HPL activity from the total rate of substrate consumption. bRef 11. cDetermined by the end point product quantification method (30).
Fig. 1.Determination of positional substrate specificity and stereospecificity of OsAOS1 by dual positional specific ZmLOX1. (A) Normal phase HPLC chromatogram from dual positional specific ZmLOX1 reaction (I, 13-(9Z,11E)-(HODE); II, 13-(9E,11E)-HODE; III, 9-(10E,12Z)-HODE; IV, 9-(10E,12E)-HODE). (B) Normal phase HPLC chromatogram showing remaining regioisomers after OsAOS1 was added to ZmLOX1 reaction mixture, (C) The relative ratios of four regioisomers from (A) and (B). The stereochemistry of each regioisomer was further analyzed by chiral phase HPLC, as shown in insets of (A) and (B).
Fig. 2.HPLC analysis of OsAOS1 reaction products. (A) 13(S)-HPODE as a substrate. (B) 13(S)-HPOTE as a substrate. The chiral phase HPLC chromatogram of cis-OPDA is shown in the inset. (C) 9(S)-HPODE as a substrate. (D) 9(S)-HPOTE as a substrate.
Fig. 3.UV-Visible and spectral shift of OsAOS1 by imidazole. (A) Visible spectra of native (black), reduced (red), carbon monoxide-treated (blue) OsAOS1. (B) Dose-dependent spectral shift of native OsAOS1 in response to imidazole. Concentrations of imidazole were shown in inset of (B). (C) Visible spectra of native (dark cyan), reduced (red), carbon monoxide-treated (blue) OsAOS1 complexed with imidazole. The inset in (A, C) shows the difference spectra obtained by subtracting the reduced form from the carbon monoxide-treated reduced form of OsAOS1. (D) Comparison of spectral shifts of native OsAOS1 by imidazole derivatives. The spectra in (D) were obtained with OsAOS1 containing 100 mM of imidazole derivatives and 30% ethanol.